Sleep disordered breathing in patients with heart failure

Cardiology Journal

Volumn 20, Issue 4, 2013, Pages 345-355

  Krawczyk, Magdalena ^a   Flinta, Irena ^a   Garncarek, Magdalena ^a   Josiak, Krystian ^a,b   Jankowska, Ewa Anita ^a,b   Banasiak, Waldemar ^a   Germany, Robin ^c,d   Javaheri, Shahrokh ^e   Ponikowski, Piotr ^a,b  

^a 4TH MILITARY HOSPITAL   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d Respicardia Inc   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Central sleep apnea; Cheyne stokes respiration; Heart failure

Indexed keywords

ACETAZOLAMIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; OPIATE; OXYGEN; PHOSPHODIESTERASE INHIBITOR; THEOPHYLLINE;

ADAPTIVE SERVOVENTILATION; APNEA HYPOPNEA INDEX; ASSISTED VENTILATION; CENTRAL SLEEP APNEA SYNDROME; CHEYNE STOKES BREATHING; DISEASE EXACERBATION; EXERCISE TOLERANCE; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART STROKE VOLUME; HUMAN; HYPERCAPNIA; HYPERVENTILATION; HYPOXIA; METABOLIC ACIDOSIS; MORTALITY; NERVE STIMULATION; NONREM SLEEP; OXYGEN THERAPY; PATHOGENESIS; PHRENIC NERVE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PROGNOSIS; QUALITY OF LIFE; REVIEW; SLEEP DISORDERED BREATHING;

COMORBIDITY; CONTINUOUS POSITIVE AIRWAY PRESSURE; HEART FAILURE; HUMANS; LUNG; PREVALENCE; RISK FACTORS; SLEEP APNEA SYNDROMES; TREATMENT OUTCOME;

EID: 84885211984     PISSN: 18975593     EISSN: 1898018X     Source Type: Journal    
DOI: 10.5603/CJ.2013.0092     Document Type: Review

References (65)

1. Javaheri S. Sleep-related breathing disorders in heart failure. In: Douglas L. Mann ed. Heart failure. A companion to Braunwald's heart disease. WB Saunders, Philadelphia 2010; 471-487.
2. Javaheri S. Heart failure. In: Kryger MH, Roth T, Dement WC eds. Principles and practices of sleep medicine. WB Saunders, Philadelphia 2011: 1400-1415.
3. Lanfranchi PA, Braghiroli A, Bosimini E et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation, 1999; 99: 1435-1440.
4. Wang H, Parker JD, Newton GE et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol, 2007;49:1625-31.
5. Javaheri S, Caref EB, Chen E, Tong KB, Abraham WT. Sleep apnea testing and outcomes in a large cohort of medicare beneficiaries with newly diagnosed heart failure. Am J Respir Crit Care Med, 2011; 183: 539-546.
6. Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol, 2007; 49: 2028-2038.
7. Arzt M, Floras JS, Logan AG et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: A post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation, 2007; 115: 3173-3180.
8. Takama N, Kurabayashi M. Effect of adaptive servo-ventilation on 1 year prognosis in heart failure patients. Circ J, 2012; 76: 661-667.
9. Hanly P, Zuberi-Khkhar N. Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med, 1996; 153: 272.
10. Jilek C, Krenn M, Sebah D et al. Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail 2011;13(1):68-75.
11. The Report of an American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep, 1999; 22: 667-689.
12. Javaheri S, Parker TJ, Wexler L et al. Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med, 1995; 122: 487-492 (Erratum, Ann Intern Med 1995; 123: 77).
13. Javaheri S. Sleep disorders in systolic heart failure: A prospective study of 100 male patients. The Final Report. Int J Cardiol, 2006; 106:21-28.
14. Ng AC, Freedman SB. Sleep disordered breathing in chronic heart failure. Heart Fail Rev, 2009; 14: 89-99.
15. Scharf C, Cho YK, Bloch KE et al. Diagnosis of sleep-related breathing disorders by visual analysis of transthoracic impedance signals in pacemakers. Circulation, 2004; 110: 2562-2567.
16. S Vazir A, Hastings PC, Dayer M et al. A high prevalence of sleep disorder breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Failure, 2007; 9: 243-250.
17. Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Topfer V. Sleep-disordered breathing in patients with symptomatic heart failure: A contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail, 2007; 9: 251-257.
18. MacDonald M, Fang J, Pittman SD, White DP, Malhotra A. The current prevalence of sleep disordered breathing in congestive heart failure patients treated with beta-blockers. J Clin Sleep Med, 2008; 4: 38-42.
19. Ferreira S, Marinho A, Patacho M et al. Prevalence and characteristics of sleep apnoea in patients with stable heart failure: Results from a heart failure clinic. Pulmonary Med, 2010; 10: 1-9.
20. Hagenah G, Beil D. Prevalence of Cheyne-Stokes respiration in modern treated congestive heart failure. Sleep Breath, 2009; 13: 181-185.
21. Bitter T, Faber L, Hering D, Langer C, Horstkotte D, Oldenburg O. Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur J Heart Fail, 2009; 11: 602-608.
22. Ward M. Periodic respiration. A short historical note. Ann R Coll Surg Engl, 1973; 52: 330-334.
23. Cheyne J. A case of apoplexy in which the fleshy part of the heart was converted into fat. Dublin Hospital Reports, 1818; 2: 216-223.
24. Javaheri S, Dempsey JA. Central sleep apnea. Comprehensive Physiology, 2013; 3: 141-163.
25. Xie A, Skatrud JB, Puleo DS, Rahko PS, Dempsey JA. Apnea-hypopnea threshold for CO2 in patients with congestive heart failure. Am J Respir Crit Care Med, 2002; 165: 1245-1250.
26. Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Eng J Med, 1999; 341: 949-954.
27. Ponikowski P, Chua TP, Anker SD et al. Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation, 2001; 104: 544-549.
28. Yumino D, Redolfi S, Ruttanaumpawan P et al. Nocturnal rostral fluid shift: A unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation, 2010; 121: 1598-1605.
29. Javaheri S, Corbett WS. Association of low arterial PCO2 with central sleep apnea and ventricular arrhythmias in ambulatory patients with stable heart failure. Ann Intern Med, 1998; 128: 204-207.
30. Javaheri S, Almoosa KF, Saleh K, Mendenhall CL. Hypocapnia is not a predictor of central sleep apnea in patients with cirrhosis. Am J Respir Crit Care Med, 2005; 171: 908-911.
31. Xie A, Skatrud JB, Barczi SR et al. Influence of cerebral blood flow on breathing stability. J Appl Physiol, 2009; 106: 850-856.
32. Georgiadis D SM, Werdan K. Cerebrovascular reactivity is impaired in patients with cardiac failure. Eur Heart J, 2000; 21: 407-413.
33. Jordan AS, White DP. Pharyngeal motor control and the pathogenesis of obstructive sleep apnea. Respir Physiol Neurobiol, 2008; 160: 1-7.
34. Javaheri S, Parker TJ, Liming JD et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation, 1998; 97: 2154-2159.
35. Ponikowski P, Anker SD, Chua TP et al. Oscillatory breathing patterns during wakefulness in patients with chronic heart failure: clinical implications and role of augmented peripheral chemosensitivity. Circulation, 1999; 100: 2418-2424.
36. Javaheri S. Shukla R, Wexler L. Association of smoking, sleep apnea and plasma alkalosis with nocturnal ventricular arrhythmias in men with systolic heart failure. Chest, 2012; 141: 1449-1456.
37. Baranchuk A. Sleep apnea, cardiac arrhythmias, and conduction disorders. J Electrocardiol, 2012; 45: 508-512.
38. Javaheri S. Treatment of obstructive and central sleep apnea in heart failure: Practical options. Eur Respir Rev, 2007; 16: 183-188.
39. Kohler M, Stradling JR. Pitfalls of clinical trials on pharmacological treatment for obstructive sleep apnoea: future directions. Expert Opin Investig Drugs, 2011; 20: 1033-1037.
40. Roizenblatt S, Guilleminault C, Poyares D, Cintra F, Kauati A, Tufik S. A double-blind, placebo-controlled, crossover study of sildenafil in obstructive sleep apnea. Arch Intern Med, 2006; 166: 1763-1767.
41. Cao M, Javaheri S. Chronic opioid use: Effects on respiration and sleep. In: Tvildiani D, Gegechkori K eds. Opioids pharmacology, clinical uses and adverse effects. Edited by Nova Science Publishers, Inc., NewYork 2012: 1-13.
42. Kaneko Y, Floras JS, Usui K et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med, 2003; 248: 1233-1241.
43. Mansfield DR, Gollogly C, Kaye DM. Controlled trail of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med, 2004; 169: 361-366.
44. Egea CJ, Aizpuru F, Pinto JA et al. Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: A multicenter study. Sleep Med, 2008; 9: 660-666.
45. Smith LA, Vennelle M, Gardner RS et al. Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: A randomized placebo-controlled trial. Eur Heart J, 2007; 28: 1221-1227.
46. Javaheri S. Heart failure. In: Kushida CA ed. The encyclopedia of sleep. Academic Press, Waltham, MA 2013; 3: 374-386.
47. Arias MA, Garcia-Rio F, Alonso-Fernandez A et al. Obstructive sleep apnea syndrome affects left ventricular diastolic function. Circulation. 2005;112:375-383.
48. Kasai T, Narui K, Dohi P et al. Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest, 2008; 133: 690-696.
49. Damy T, Margarit L, Noroc A, Bodez D et al. Prognostic impact of sleep-disordered breathing and its treatment with nocturnal ventilation for chronic heart failure. Eur J Heart Fail, 2012; 14: 1009-1019.
50. Tamura A, Kawano Y, Naono S, Kotoku M, Kadota J. Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest, 2007; 131: 130-135.
51. Lamba J, Simpson CS, Redfearn DP, Michael KA, Fitzpatrick M, Baranchuk A. Cardiac resynchronization therapy for the treatment of sleep apnoea: a meta-analysis. Europace 2011;13: 1174-9.
52. Javaheri S. Pembrey's dream: The time has come for a long-term trial of nocturnal supplemental nasal oxygen to treat central sleep apnea in congestive heart failure. Chest, 2003; 123: 322-325.
53. Javaheri S, Parker TJ, Wexler L, Liming JD, Lindower P, Roselle GA. Effects of theophylline on sleep disordered breathing in stable heart failure: A prospective, double-blind, placebo controlled, crossover study. N Engl J Med, 1996; 335: 562-567.
54. Javaheri S. Acetazolamide improves central sleep apnea in heart failure: A double-blind prospective study. Am J Respir Crit Care Med, 2006; 173: 234-237.
55. Sasayama S, Izumi T, Seino Y et al. Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and Cheyne-Stokes respiration. Circ J, 2006; 70: 1-7.
56. Sasayama S, Izumi T, Matsuzaki M et al. Improvement of quality of life with nocturnal oxygen therapy in heart failure patients with central sleep apnea. Circ J, 2009; 73: 1255-1262.
57. Toyama T, Seki R, Kasama S et al. Effectiveness of nocturnal home oxygen therapy to improve exercise capacity, cardiac function and cardiac sympathetic nerve activity in patients with chronic heart failure and central sleep apnea. Circ J, 2009; 73: 299-304.
58. Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation, 2000; 101: 392-397.
59. Bradley TD, Logan AG, Kimoff RJ et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Eng J Med, 2005; 353: 2025-2033.
60. Javaheri S. CPAP should not be used for central sleep apnea in congestive heart failure patients. J Clin Sleep Med, 2006; 15: 399-402.
61. Harris N. Javaheri S. Advanced PAP therapies. In:Mattice C, Brooks R, Lee-Chiong T eds. Fundamentals of sleep technology. Lippincott, Williams and Wilkins, Philadelphia 2012; 444-452.
62. Teschler H, Döhring J, Wang YM et al. Adaptive pressure support servo-ventilation. Am J Respir Crit Care Med, 2001; 164: 614.
63. Sharma BK, Bakker JP, McSharry DG, Desai AS, Javaheri S, Malhotra A. Adaptive servo-ventilation for treatment of sleepdisordered breathing in heart failure: A systematic review and meta-analysis. Chest, 2012; 142: 1211-1221.
64. Ponikowski P, Javaheri S, Michalkiewicz D et al. Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure. Eur Heart J, 2012; 33: 889-894.
65. Javaheri S, Abraham W, Brown C et al. Prevalence of obstructive sleep apnea and periodic limb movement in 45 subjects with heart transplantation. Eur Heart J, 2004; 25: 260-266.